Provided by Tiger Trade Technology Pte. Ltd.

Cabot

77.56
-0.9000-1.15%
Pre-market: 77.560.00000.00%04:00 EDT
Volume:323.19K
Turnover:25.18M
Market Cap:4.00B
PE:21.80
High:79.65
Open:79.65
Low:77.35
Close:78.46
52wk High:94.53
52wk Low:58.33
Shares:51.62M
Float Shares:50.93M
Volume Ratio:0.78
T/O Rate:0.63%
Dividend:1.82
Dividend Rate:2.35%
EPS(TTM):3.56
EPS(LYR):6.02
ROE:13.35%
ROA:8.90%
PB:2.49
PE(LYR):12.88

Loading ...

Cabot Corp Is Maintained at Neutral by UBS

Dow Jones
·
May 09

Cabot price target raised to $86 from $81 at UBS

TIPRANKS
·
May 09

UBS Adjusts Price Target on Cabot to $86 From $81, Maintains Neutral Rating

MT Newswires Live
·
May 08

Cabot Revelstoke Announces Expansion Plans and Updates Ahead of Its Highly Anticipated British Columbia Debut

THOMSON REUTERS
·
May 07

GUIDANCE: (CBT) Cabot Expects 2026 Adjusted EPS Range $6.00-$6.50, vs. FactSet Est of $6.23

MT Newswires Live
·
May 06

Earnings Flash (CBT) Cabot Posts Fiscal Q2 Adjusted EPS $1.61, vs. FactSet Est of $1.46

MT Newswires Live
·
May 06

Cabot Q2 adjusted EPS beats estimates

Reuters
·
May 06

Cabot Q2 Adj. EPS $1.61 Beats $1.46 Estimate, Sales $904.000M Beat $900.305M Estimate

Benzinga Earnings
·
May 06

BRIEF-Cabot Q2 Adjusted EPS USD 1.61 Vs. IBES Estimate USD 1.46

Reuters
·
May 06

Cabot: Outlook Reflects Expected Impact of Middle East Conflict

THOMSON REUTERS
·
May 06

Cabot Q2 Sales USD 904 Million VS. Ibes Estimate USD 900.3 Million

THOMSON REUTERS
·
May 06

Cabot: Cautious of Potential Changes in Demand Levels Towards the End of 2026 Due to Disruptions From Middle East Crisis

THOMSON REUTERS
·
May 06

Press Release: Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results

Dow Jones
·
May 06

Cabot increases quarterly dividend 5% to 47.25c per share

TIPRANKS
·
May 05

Cabot Corp - Declares Qtrly Dividend of $0.4725 per Share, up 5%

THOMSON REUTERS
·
May 05

Press Release: Cabot Corporation Board Increases Dividend

Dow Jones
·
May 05

CLOUDBREAK-B Receives FDA Clearance for Safety Review of CBT-199

Stock News
·
Apr 30

Earning Preview: Cabot revenue expected to decrease by 12.10% this quarter, and institutional views are cautious

Earnings Agent
·
Apr 28

Cabot sets webcast and conference call for fiscal Q2 operating results

Reuters
·
Apr 09

BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions

GlobeNewswire
·
Apr 08